You won't believe what Pfizer is trying to do now

First published at 07:47 UTC on June 5th, 2023.

Data Dumper



Redacted, June 4, 2023

"The FDA approved a vaccine for RSV from Pfizer on Wednesday for adults ages 60 and up only. Experts say that the market for an RSV vaccine could reach $15 billion per year. In fact, vaccine makers have partnered with ba…

CategoryHealth & Medical
SensitivityNormal - Content that is suitable for ages 16 and over